173 related articles for article (PubMed ID: 1911712)
1. Attenuation of atherosclerosis in a modified strain of hypercholesterolemic Watanabe rabbits with use of a probucol analogue (MDL 29,311) that does not lower serum cholesterol.
Mao SJ; Yates MT; Parker RA; Chi EM; Jackson RL
Arterioscler Thromb; 1991; 11(5):1266-75. PubMed ID: 1911712
[TBL] [Abstract][Full Text] [Related]
2. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.
Kita T; Nagano Y; Yokode M; Ishii K; Kume N; Ooshima A; Yoshida H; Kawai C
Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5928-31. PubMed ID: 3475709
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of probucol in reducing plasma low-density lipoprotein cholesterol oxidation in hypercholesterolemia.
Masana L; Bargalló MT; Plana N; LaVille A; Casals I; Solà R
Am J Cardiol; 1991 Oct; 68(9):863-7. PubMed ID: 1927944
[TBL] [Abstract][Full Text] [Related]
4. Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
Kleinveld HA; Demacker PN; Stalenhoef AF
Arterioscler Thromb; 1994 Aug; 14(8):1386-91. PubMed ID: 8049202
[TBL] [Abstract][Full Text] [Related]
5. A water-extract of the Korean traditional formulation Geiji-Bokryung-Hwan reduces atherosclerosis and hypercholesteremia in cholesterol-fed rabbits.
Kim BJ; Kim YK; Park WH; Ko JH; Lee YC; Kim CH
Int Immunopharmacol; 2003 May; 3(5):723-34. PubMed ID: 12757741
[TBL] [Abstract][Full Text] [Related]
6. The in vitro and ex vivo antioxidant properties, and hypolipidemic activity of CGP 2881.
Feldman DL; Mogelesky TC; Sharif R; Sawyer WK; Jeune M; Hu CW; Leonards KS; Prescott MF
Atherosclerosis; 1999 Jun; 144(2):343-55. PubMed ID: 10407495
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant activity of probucol and its analogues in hypercholesterolemic Watanabe rabbits.
Mao SJ; Yates MT; Rechtin AE; Jackson RL; Van Sickle WA
J Med Chem; 1991 Jan; 34(1):298-302. PubMed ID: 1992130
[TBL] [Abstract][Full Text] [Related]
8. Probucol treatment attenuates the aortic atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
Oshima R; Ikeda T; Watanabe K; Itakura H; Sugiyama N
Atherosclerosis; 1998 Mar; 137(1):13-22. PubMed ID: 9568732
[TBL] [Abstract][Full Text] [Related]
9. Effect of the antioxidant probucol on transplant arteriosclerosis in aorta-allografted rabbits.
Andersen HO; Holm P; Nordestgaard BG; Hansen BF; Kjeldsen K; Elinder LS; Stender S
J Mol Cell Cardiol; 1995 Aug; 27(8):1561-71. PubMed ID: 8523419
[TBL] [Abstract][Full Text] [Related]
10. The effects of probucol on the progression of atherosclerosis in mature Watanabe heritable hyperlipidaemic rabbits.
Daugherty A; Zweifel BS; Schonfeld G
Br J Pharmacol; 1991 May; 103(1):1013-8. PubMed ID: 1878742
[TBL] [Abstract][Full Text] [Related]
11. Increase of vitamin E content in LDL and reduction of atherosclerosis in cholesterol-fed rabbits by a water-soluble antioxidant-rich fraction of Salvia miltiorrhiza.
Wu YJ; Hong CY; Lin SJ; Wu P; Shiao MS
Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):481-6. PubMed ID: 9514418
[TBL] [Abstract][Full Text] [Related]
12. Combined effects of probucol and benzafibrate on lipoprotein metabolism and liver cholesteryl ester transfer protein mRNA in cholesterol-fed rabbits.
Ou J; Saku K; Jimi S; Liao YL; Ohta T; Zhang B; Arakawa K
Jpn Circ J; 1999 Jun; 63(6):471-7. PubMed ID: 10406588
[TBL] [Abstract][Full Text] [Related]
13. Atherosclerotic lesion development in hypercholesterolemic Japanese quail following probucol treatment: a biochemical and morphologic evaluation.
Bocan TM; Mazur MJ; Mueller SB; Charlton G; Kieft KA; Krause BR
Pharmacol Res; 1994; 29(1):65-76. PubMed ID: 8202444
[TBL] [Abstract][Full Text] [Related]
14. Probucol selectively increases oxidation of atherogenic lipoproteins in cholesterol-fed mice and in Watanabe heritable hyperlipidemic rabbits.
Lauridsen ST; Mortensen A
Atherosclerosis; 1999 Jan; 142(1):169-78. PubMed ID: 9920518
[TBL] [Abstract][Full Text] [Related]
15. Probucol inhibits the initiation of atherosclerosis in cholesterol-fed rabbits.
Niimi M; Keyamura Y; Nozako M; Koyama T; Kohashi M; Yasufuku R; Yoshikawa T; Fan J
Lipids Health Dis; 2013 Nov; 12():166. PubMed ID: 24188322
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of a novel water-soluble vitamin E derivative on atherosclerosis in rabbits.
Yoshida N; Murase H; Kunieda T; Toyokuni S; Tanaka T; Terao J; Naito Y; Tanigawa T; Yoshikawa T
Atherosclerosis; 2002 May; 162(1):111-7. PubMed ID: 11947904
[TBL] [Abstract][Full Text] [Related]
17. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.
Carew TE; Schwenke DC; Steinberg D
Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7725-9. PubMed ID: 3478721
[TBL] [Abstract][Full Text] [Related]
18. Extent of antioxidant protection of plasma LDL is not a predictor of the antiatherogenic effect of antioxidants.
Fruebis J; Bird DA; Pattison J; Palinski W
J Lipid Res; 1997 Dec; 38(12):2455-64. PubMed ID: 9458269
[TBL] [Abstract][Full Text] [Related]
19. Dual effects of the antioxidant agents probucol and carvedilol on proliferative and fatty lesions in hypercholesterolemic rabbits.
Donetti E; Soma MR; Barberi L; Paoletti R; Fumagalli R; Roma P; Catapano AL
Atherosclerosis; 1998 Nov; 141(1):45-51. PubMed ID: 9863537
[TBL] [Abstract][Full Text] [Related]
20. Preservation of endothelium-dependent relaxation in atherosclerotic rabbit aorta by probucol.
Simon BC; Haudenschild CC; Cohen RA
J Cardiovasc Pharmacol; 1993 Jun; 21(6):893-901. PubMed ID: 7687713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
